Lazard Asset Management »

Merrimack Pharma shares owned by Lazard Asset Management

Quarter-by-quarter ownership of Merrimack Pharma (MACK) shares owned by Lazard Asset Management from 13F filings

Historical chart of Lazard Asset Management investment in Merrimack Pharma

Tip: Access up to 7 years of quarterly data

All positions including Merrimack Pharma held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Merrimack Pharma by Lazard Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $37k 2.8k 13.07
2023-09-30 $38k 3.1k 12.17
2023-06-30 $38k 3.1k 12.17
2023-03-31 $60k 5.0k 12.12

More positions owned by Lazard Asset Management

Microsoft Corp Common Stock (MSFT)
Alphabet Inc A Common Stock (GOOGL)
Amazon.com Common Stock (AMZN)
Norfolk Souther Common Stock (NSC)
Visa Common Stock (V)
Accenture Common Stock (ACN)
Intercontinen Common Stock (ICE)
Unitedhealth Gr Common Stock (UNH)
Aon Plc/ireland Common Stock (AON)
Bank Of America Common Stock (BAC)
Thermo Fisher Common Stock (TMO)
Analog Devices Common Stock (ADI)
Mcdonalds Corp Common Stock (MCD)
John & John Common Stock (JNJ)
Amer Express Common Stock (AXP)

View all positions for Lazard Asset Management

Top funds holding Merrimack Pharma

Western Standard
Newtyn Management
Vanguard Group
Madison Avenue Partners
ADAR1 Capital Management
Dimensional Fund Advisors
Sepio Capital
Indaba Capital Management
Wittenberg Investment Management
Caption Management
Bank of New York Mellon
Kennedy Capital Management
Goldman Sachs Group
Citadel Advisors
Charles Schwab Investment Management

View all funds holding Merrimack Pharma